The first cannabanoid-1 receptor antagonist to enter clinical trials was rimonabant, which showed excellent weight loss outcomes with an additional mean weight loss of 4.7 kg [102]
But the biggest change for Steward and one that didn't occur with the gastric bypass has been the "food noise" in her brain turning off
With zero sugar and fast-absorbing liquid delivery, this formula provides clean, stimulant-free support for fat metabolism, thermogenic activity, and sustained energy
However, the effects on gastric emptying may diminish more rapidly due to tachyphylaxis (reduced response over time)
Its not just about chasing numbers
Statistical analyses Statistical tests were completed using GraphPad Prism v.9.0 (GraphPad Software, La Jolla, CA, USA)